Agenus
Patents, Design & Utilities
Last updated:
List of all Agenus patents 75 in total
| Status | Patent |
|---|---|
Grant | Utility: Antibodies and methods of use thereof Filling date: 5 Sep 2025 Issue date: 20 Sep 2022 |
Application | Utility: ANTIGENIC POLYPEPTIDES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: ANTIGENIC POLYPEPTIDES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 18 Aug 2022 |
Grant | Utility: Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies Filling date: 5 Sep 2025 Issue date: 16 Aug 2022 |
Grant | Utility: Anti-GITR antibodies and methods of use thereof Filling date: 5 Sep 2025 Issue date: 2 Aug 2022 |
Application | Utility: ANTI-CD137 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 28 Jul 2022 |
Grant | Utility: Anti-OX40 antibodies and anti-GITR antibodies Filling date: 5 Sep 2025 Issue date: 14 Jun 2022 |
Grant | Utility: Anti-PD-1 antibodies and methods of use thereof Filling date: 5 Sep 2025 Issue date: 31 May 2022 |
Grant | Utility: Vectors comprising nucleic acids encoding anti-OX40 antibodies Filling date: 5 Sep 2025 Issue date: 17 May 2022 |
Application | Utility: ANTI-CD137 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: ANTI-OX40 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: ANTI-TIGIT ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 24 Mar 2022 |
Grant | Utility: Anti-CTLA-4 antibodies and methods of use thereof Filling date: 5 Sep 2025 Issue date: 8 Mar 2022 |
Application | Utility: CLASS I MHC PHOSPHOPEPTIDES FOR CANCER IMMUNOTHERAPY AND DIAGNOSIS Filling date: 5 Sep 2025 Issue date: 10 Feb 2022 |
Grant | Utility: Anti-CD137 antibodies and methods of use thereof Filling date: 5 Sep 2025 Issue date: 8 Feb 2022 |
Application | Utility: ANTI-ILT4 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS Filling date: 5 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: Heat Shock Protein-Binding Peptide Compositions And Methods Of Use Thereof Filling date: 5 Sep 2025 Issue date: 13 Jan 2022 |
Application | Utility: ANTI-OX40 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 21 Oct 2021 |
Grant | Utility: Anti-OX40 antibodies Filling date: 5 Sep 2025 Issue date: 5 Oct 2021 |
Grant | Utility: Anti-CD137 antibodies and methods of use thereof Filling date: 5 Sep 2025 Issue date: 24 Aug 2021 |
Application | Utility: ANTI-TIM-3 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 19 Aug 2021 |
Grant | Utility: Heat shock protein-binding peptide compositions and methods of use thereof Filling date: 5 Sep 2025 Issue date: 20 Jul 2021 |
Application | Utility: ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 8 Jul 2021 |
Grant | Utility: Anti-ILT4 antibodies and antigen-binding fragments Filling date: 5 Sep 2025 Issue date: 6 Jul 2021 |
Application | Utility: ANTI-LAG-3 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 10 Jun 2021 |
Grant | Utility: Anti-TIGIT antibodies and methods of use thereof Filling date: 5 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Anti-CTLA-4 antibodies and methods of use thereof Filling date: 5 Sep 2025 Issue date: 25 May 2021 |
Application | Utility: HETERODIMERIC PROTEINS Filling date: 5 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: ANTI-CD137 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: ANTI-CD96 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: ANTI-GITR ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: ANTI-LAG-3 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 25 Feb 2021 |
Grant | Utility: Anti-CTLA-4 antibodies and methods of use thereof Filling date: 5 Sep 2025 Issue date: 9 Feb 2021 |
Grant | Utility: Anti-TIM-3 antibodies and methods of use thereof Filling date: 5 Sep 2025 Issue date: 9 Feb 2021 |
Application | Utility: ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 28 Jan 2021 |
Grant | Utility: Anti-LAG-3 antibodies and methods of use thereof Filling date: 5 Sep 2025 Issue date: 5 Jan 2021 |
Application | Utility: IDENTIFICATION OF MHC CLASS I PHOSPHO-PEPTIDE ANTIGENS FROM BREAST CANCER UTILIZING SHLA TECHNOLOGY AND COMPLEMENTARY ENRICHMENT STRATEGIES Filling date: 5 Sep 2025 Issue date: 24 Dec 2020 |
Grant | Utility: Anti-LAG-3 antibodies and methods of use thereof Filling date: 5 Sep 2025 Issue date: 24 Nov 2020 |
Application | Utility: ANTI-LAG-3 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 19 Nov 2020 |
Grant | Utility: Antibodies and methods of use thereof Filling date: 5 Sep 2025 Issue date: 17 Nov 2020 |
Application | Utility: ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: ANTI-PD-1 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 12 Nov 2020 |
Grant | Utility: Anti-GITR antibodies and methods of use thereof Filling date: 5 Sep 2025 Issue date: 10 Nov 2020 |
Application | Utility: ANTI-GITR ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 29 Oct 2020 |
Grant | Utility: Anti-GITR antibodies and methods of use thereof Filling date: 5 Sep 2025 Issue date: 13 Oct 2020 |
Application | Utility: ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: ANTI-OX40 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: T CELL RECEPTORS THAT BIND TO MIXED LINEAGE LEUKEMIA (MLL)-SPECIFIC PHOSPHOPEPTIDES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 1 Oct 2020 |
Showing 1 to 50 of 75 patents.